CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM by I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek

Subjects: Get full text

Analysis of assortment and volumes of consumption of antihistamin preparations in Ukraine by L.V. Iakovlieva, O. G. Berdnik, A. A. Gurtyakova

Subjects: Get full text

Economic evaluation of isosorbide mononitrate sustained-release capsules for the treatment of angina pectoris by Yuhang Liu, Jienan Zheng, Yeyou Xu, Shuli Zhang, Yueyun Li, Hui Zhang

Subjects: Get full text

Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and Opportunities by Anas Hamad, Mai Alsaqa’aby, Yazed Alruthia, Sara Aldallal, Gihan Hamdy Elsisi

Subjects: Get full text

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis by Antonio Lacquaniti, Romana Gargano, Susanna Campo, Teresa Casuscelli di Tocco, Silvia Schifilliti, Paolo Monardo

Subjects: Get full text

Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them by S. V. Ponomarenko

Subjects: Get full text

METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES by R. I. Yagudina, I. V. Sorokovikov

Subjects: “…pharmacoeconomics…”
Get full text

PRIMARY OPEN-ANGLE GLAUCOMA AND FARMACOECONOMICS - REVIEW by Sarenac Vulovic Tatjana, Janicijevic Katarina

Subjects: Get full text

BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina

Subjects: “…pharmacoeconomics…”
Get full text

Basic and clinical research in oncology: is there background for a breakthrough? by N. V. Zhukov, S. A. Rumyantsev, S. A. Lukyanov

Subjects: Get full text

Analysis of the cost-effectiveness of early diagnosis and pharmacotherapy of pulmonary arterial hypertension by I. S. Datsenko

Subjects: Get full text

Basic and clinical research in oncology: is there background for a breakthrough? by N. V. Zhukov, S. A. Rumyantsev, S. A. Lukyanov

Subjects: Get full text

Evaluation of Pattern of Oral Hypoglycaemic Agents Usage and their Cost among Type-2 Diabetic Patients in a Tertiary Care Teaching Hospital by Selvalaxmi Gnanasegaran, Srija Gopal, Sakthibalan Murugesan, Gerard Marshall Raj, Mangaiarkkarasi Adhimoolam

Subjects: Get full text

RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION by A.A. Baranov, V.V. Omel'yanovskii, N.I. Briko, Yu.V. Lobzin, L.S. Namazova-Baranova, V.K. Tatochenko, S.M. Kharit, S.V. Sidorenko, I.S. Koroleva, A.E. Platonov, G.Yu. Moisyak, I.S. Krysanov, O.I. Ivakhnenko, F.M. Tsfasman

“…The article discusses the first results of a pharmacoeconomic analysis of the efficacy of using the Pneumococcal conjugated 7-valent vaccine (PCV7) for immunization of children aged 2 months to 5 years in Russia using techniques for modeling various approaches to cohort immunization. …”
Get full text

Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation by R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova, I. Yu. Torshin

Subjects: Get full text

Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer by S. К. Zyryanov, I. N. Dyakov

“…Objective: to evaluate the pharmacoeconomic efficacy of “atezolizumab + bevacizumab + paclitaxel + carboplatin” drug combination compared to “pembrolizumab + pemetrexed + carboplatin” combination in adult patients with non-small cell lung cancer (NSCLC) in the first line of therapy.Material and methods. …”
Get full text

RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION by A.A. Baranov, V.V. Omel'yanovskii, N.I. Briko, Yu.V. Lobzin, L.S. Namazova-Baranova, V.K. Tatochenko, S.M. Kharit, S.V. Sidorenko, I.S. Koroleva, A.E. Platonov, G.Yu. Moisyak, I.S. Krysanov, O.I. Ivakhnenko, F.M. Tsfasman

“…The article discusses the first results of a pharmacoeconomic analysis of the efficacy of using the Pneumococcal conjugated 7-valent vaccine (PCV7) for immunization of children aged 2 months to 5 years in Russia using techniques for modeling various approaches to cohort immunization. …”
Get full text

Adherence to Consolidated Health Economic Evaluation Reporting Standards guidelines for published pharmacoeconomic studies in PubMed-indexed medical journals over a year (2021–2022) by Miteshkumar Maurya, Renuka Munshi

Get full text

Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients by N. K. Mazina, P. V. Mazin

Subjects: Get full text

Direct Oral Anticoagulants’ Consumption and Expenditure in the COVID-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use by Elena A. Baybulatova, Mikhail S. Chenkurov, Elina A. Korovyakova, Sergey K. Zyryanov, Liliya Eugenevna Ziganshina

Subjects: Get full text